How They Work: The NAD+ Pathway

Both NMN and NR convert to NAD+ through your body’s salvage pathway—but they enter at different points:

NMN is essentially “one step ahead” in the pathway. It’s the immediate precursor to NAD+, requiring just one enzyme (NMNAT) to complete the conversion. NR must first be converted to NMN (by NRK enzymes), then NMN converts to NAD+.

In theory, being one step closer gives NMN an advantage. In practice, the NR → NMN conversion is rapid and efficient, so this difference may not be as meaningful as it sounds biochemically.

The NMN Transporter Discovery

In 2019, researchers discovered that NMN has its own dedicated cellular transporter—a protein called Slc12a8. This transporter actively helps NMN enter cells directly from the bloodstream, rather than relying solely on conversion outside the cell.

This was a notable finding because it suggests NMN can enter cells intact, potentially improving its effectiveness. NR doesn’t have the same dedicated transporter (though it uses other uptake mechanisms).

Whether this translates to meaningfully better outcomes in humans is still being studied. Some researchers consider it a meaningful advantage for NMN; others argue the practical difference is minimal.

Key Differences: NMN vs NR

Research Comparison

NR Research (More Extensive)

NR currently has the most published human clinical trials of any oral NAD+ precursor:

• 2018 Martens study: 1000mg NR daily increased NAD+ by ~60% in 6 weeks; well-tolerated in healthy middle-aged and older adults
• 2017 Airhart study: Established pharmacokinetics showing NR is absorbed and raises NAD+ metabolites
• 2019 Conze study: Long-term safety data for Niagen NR with no concerning adverse effects
• Multiple additional trials: Examining cardiovascular health, cognitive function, muscle performance

NR’s research advantage is real—if published clinical evidence is your primary decision factor, NR has the stronger track record.

NMN Research (Growing Rapidly)

NMN research has accelerated since 2020:

• 2021 Yoshino study: 250mg NMN daily increased muscle insulin sensitivity in prediabetic women (published in Science)
• 2022 studies: Multiple trials showing NMN increases blood NAD+ levels and improves various health markers
• 2019 Slc12a8 discovery: Established that NMN has a dedicated cellular transporter for direct uptake
• David Sinclair’s work: Ongoing research at Harvard focusing on NMN and longevity mechanisms

NMN research is catching up quickly. The gap that existed a few years ago has narrowed considerably, and both now have solid research foundations.

Which Raises NAD+ More?

Both NMN and NR effectively raise NAD+ levels. Direct head-to-head comparisons in humans are limited, but available evidence suggests similar effectiveness at comparable doses.

What studies show:

• NR (1000mg/day) → ~60% NAD+ increase after 6 weeks
• NMN (250mg/day) → ~38% NAD+ increase after 12 weeks

These numbers aren’t directly comparable (different doses, populations, measurement methods), but both demonstrate meaningful NAD+ elevation.

The NMN transporter (Slc12a8) theoretically gives it an absorption advantage, but this hasn’t translated to dramatically different outcomes in published studies. You’ll likely see similar benefits from either—consistency of daily use matters more than the molecule you choose.

Cost Comparison

Pricing is relatively similar, though NR brands tend to be slightly cheaper on average:

Quality matters more than minor price differences. Both NR and NMN can degrade if improperly manufactured or stored. Stick with reputable brands that provide third-party testing.

Which Should You Choose?

Choose NMN If:

• You want the “closer” precursor — NMN is one step from NAD+, not two
• The Slc12a8 transporter research appeals to you — Direct cellular uptake mechanism
• You follow David Sinclair’s work — His research focuses on NMN
• You prefer newer research — NMN studies tend to be more recent
• You want higher typical doses — NMN dosing tends to be lower mg but similar effect

Choose NR If:

• Maximum research backing matters — NR has the most published human trials
• You prefer established brands — Tru Niagen has been around longer with more safety data
• You want slightly lower cost — NR tends to be a bit cheaper
• You value long-term safety data — More years of human use documented
• You want GRAS status — NR was granted GRAS by FDA in 2016

Either Works If:

• You just want to boost NAD+ effectively—both accomplish this
• You’re not attached to specific research arguments
• You’d rather pick a quality brand than debate molecules
• You plan to try one, assess response, and potentially switch if needed

What Does David Sinclair Take?

David Sinclair, the Harvard geneticist whose research popularized NAD+ supplementation, has publicly stated he takes NMN (along with resveratrol, metformin, and other compounds). His research lab focuses heavily on NMN.

However, Sinclair acknowledges that NR is also effective. The “Sinclair takes NMN” factor has influenced many people’s choices, but it’s worth noting that his personal regimen isn’t necessarily optimal for everyone—and researchers debate whether his public statements constitute a conflict of interest given his commercial ties.

Charles Brenner, who discovered NR’s role as an NAD+ precursor, naturally advocates for NR and has published extensively on its benefits.

Both researchers are credible, and both molecules work. Don’t over-weight any single researcher’s personal choices.

Can You Take Both NMN and NR?

You can, but most people don’t see the need. Since both convert to NAD+ through overlapping pathways, taking both may be redundant rather than synergistic.

Some people do combine them experimentally, reasoning that different absorption mechanisms might complement each other. There’s no evidence of harm from combining—you’re just supporting NAD+ production through multiple precursors.

A more common combination is pairing either NMN or NR with:

• TMG (trimethylglycine) — Supports methylation, which NAD+ synthesis consumes
• Resveratrol — Sirtuin activator that may work synergistically with higher NAD+
• Periodic NAD+ IV — For intensive boosts beyond what oral precursors achieve

The Bottom Line

NMN and NR are both effective oral NAD+ precursors. The debate over which is “better” continues in longevity circles, but practical differences are minimal:

• NMN: 1 step to NAD+, dedicated transporter, growing research, Sinclair’s choice
• NR: 2 steps to NAD+, most human trials, established brands, longer safety record

Pick a quality product from either category and you’ll likely see similar benefits. Consistency matters more than the NMN/NR debate. Take it daily, give it 4-8 weeks, and assess your response.

If you try one and don’t see results after 2-3 months, consider switching to the other, adjusting dose, or exploring NAD+ IV therapy for more intensive effects.